Amrita Krishnan, MD, elaborates on BCMA-directed strategies for multiple myeloma patients OBRoncology 1:37 5 years ago 54 Далее Скачать
Amrita Krishnan M.D., on Treatment Options for Multiple Myeloma | #ASCO21 City of Hope 1:17 3 years ago 155 Далее Скачать
Sequencing of BCMA-directed therapies for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:21 5 months ago 51 Далее Скачать
Amrita Krishnan, MD on the Best Myeloma Maintenance Approach After Transplant — IMW 2019 HealthTree Foundation for Multiple Myeloma 2:16 5 years ago 536 Далее Скачать
Amrita Krishnan, M.D., Discusses a New Class of Myeloma Therapies | #ASCO21 City of Hope 1:32 3 years ago 210 Далее Скачать
How BCMA targeting bispecific antibodies may impact the subsequent use of CAR-T therapy in myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:15 2 years ago 73 Далее Скачать
Symposium | Beyond BCMA: Novel strategies using bispecific antibodies Multiple Myeloma Hub 19:00 8 months ago 184 Далее Скачать
Meet Multiple Myeloma Specialist Amrita Krishnan, M.D. | City of Hope Orange County City of Hope Orange County 1:45 4 years ago 495 Далее Скачать
Teclistamab’s place in the myeloma treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 0:41 2 years ago 110 Далее Скачать
Dr. Krishnan on Key Aspects of the ELOQUENT Trials in Relapsed/Refractory Multiple Myeloma OncLive 1:16 5 years ago 87 Далее Скачать
Optimal strategies to manage late-stage multiple myeloma: the promise of anti-BCMA therapies VJHemOnc – Video Journal of Hematology & HemOnc 3:15 2 years ago 322 Далее Скачать
The evolving treatment landscape for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:30 3 years ago 86 Далее Скачать
The efficacy of cevostamab in R/R multiple myeloma and the importance of bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 85 Далее Скачать
Dr. Amrita Krishnan: Virtual NBC4 Broadcast | City of Hope Orange County City of Hope Orange County 2:15 4 years ago 236 Далее Скачать
What is BCMA Directed therapy? #myeloma HealthTree University for Multiple Myeloma 2:14 10 months ago 434 Далее Скачать
Bispecific BCMA-CD3 antibody teclistamab is efficacious and tolerable in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:29 4 years ago 87 Далее Скачать
